Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis

被引：0
|
作者：
Silverberg, Jonathan, I [1 ]
Bieber, Thomas [2 ,3 ]
Paller, Amy [4 ]
Beck, Lisa A. [5 ]
Kamata, Masahiro [6 ]
Puig, Luis [7 ]
Wiseman, Marni [8 ,9 ]
Ezzedine, Khaled [10 ]
Foley, Peter [11 ]
Johansson, Erin [12 ]
Dossenbach, Martin [12 ]
Akmaz, Bulent [13 ]
Casillas, Marta [12 ]
Karlsson, Andrei [14 ]
Chovatiya, Raj [15 ]
机构：
[1] George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, Washington, DC USA
[2] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany
[3] Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland
[4] Northwestern Univ, Dept Dermatol, Chicago, IL USA
[5] Univ Rochester, Med Ctr, Rochester, NY USA
[6] Teikyo Univ, Sch Med, Dept Dermatol, Tokyo, Japan
[7] Hosp Santa Creu & Sant Pau, Dept Dermatol, Barcelona, Spain
[8] Univ Manitoba, Sect Dermatol, Winnipeg, MB, Canada
[9] SKiNWISE Dermatol, Winnipeg, MB, Canada
[10] Univ Paris Est, EpiDermE, Paris, France
[11] Skin Hlth Inst, Melbourne, Vic, Australia
[12] Eli Lilly & Co, Indianapolis, IN USA
[13] Almirall SA, Barcelona, Spain
[14] Costello Med, London, England
[15] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
atopic dermatitis; lebrikizumab; network meta-analysis; targeted systemic therapy;
D O I：
10.1093/bjd/ljae266.014
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
630
引用
收藏
页码：15 / 16
页数：2
相关论文
共 50 条
  • [11] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Bernardo, Diana
    Bieber, Thomas
    Torres, Tiago
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 753 - 764
  • [12] Efficacy and Safety of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Meta-Analysis
    Meher, Bikash R.
    Mishra, Archana
    Behera, Biswanath
    Ponnusamy, Subashri
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [13] Network meta-analysis on the efficacy and safety of upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis
    Qiu, Mei
    Duan, Xue-Yan
    Yin, Dao-Gen
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (01) : E24 - E26
  • [14] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Okragly, Angela
    Sun, Zhe
    Mena, Laura Rebeca
    Hahn, Nathan
    Nickoloff, Brian J.
    Siu, Kimberly
    Gallo, Gaia
    Wolf, Eric
    Eyerich, Kilian
    Aparici, Monica
    Benschop, Robert J.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II4 - II5
  • [15] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, E.
    Okragly, A.
    Sun, Z.
    Mena, L. R.
    Hahn, N.
    Nickoloff, B. J.
    Siu, K.
    Gallo, G.
    Wolf, E.
    Eyerich, K.
    Aparici, M.
    Benschop, R. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S364 - S364
  • [16] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, E.
    Okragly, A.
    Sun, Z.
    Mena, L.
    Hahn, N.
    Nickoloff, B.
    Siu, K.
    Gallo, G.
    Wolf, E.
    Eyerich, K.
    Aparici, M.
    Benschop, R.
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (03)
  • [17] The efficacy and safety of lebrikizumab monotherapy for the management of moderate to severe atopic dermatitis: A systematic review and meta-analysis
    Bashrahil, B.
    Alzahrani, Z.
    Aman, A.
    Samarkandy, S.
    Jfri, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S106 - S106
  • [18] Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: A network meta-analysis
    Wan, Huiying
    Jia, Haiping
    Xia, Tian
    Zhang, Dingding
    DERMATOLOGIC THERAPY, 2022, 35 (09)
  • [19] Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic dermatitis: a systematic literature review and network meta-analysis
    Silverberg, J. I.
    Thyssen, J. P.
    Fahrbach, K.
    Mickle, K.
    Cappelleri, J. C.
    Romero, W.
    Cameron, M. C.
    Myers, D. E.
    Clibborn, C.
    DiBonaventura, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (09) : 1797 - 1810
  • [20] Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis
    Arents, Bernd W. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (06) : 694 - 694
12345